Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP549851.RAicEWBN7xVG4bhl6HHQ8VI5DR4V_bx4SZX96Qpa6nqPM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP549851.RAicEWBN7xVG4bhl6HHQ8VI5DR4V_bx4SZX96Qpa6nqPM130_assertion type Assertion NP549851.RAicEWBN7xVG4bhl6HHQ8VI5DR4V_bx4SZX96Qpa6nqPM130_head.
- NP549851.RAicEWBN7xVG4bhl6HHQ8VI5DR4V_bx4SZX96Qpa6nqPM130_assertion description "[Target evaluation of parasitic DHS has recently been performed with CNI-1493, a novel selective pro-inflammatory cytokine inhibitor used in clinical phase II for the treatment of Crohn's disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP549851.RAicEWBN7xVG4bhl6HHQ8VI5DR4V_bx4SZX96Qpa6nqPM130_provenance.
- NP549851.RAicEWBN7xVG4bhl6HHQ8VI5DR4V_bx4SZX96Qpa6nqPM130_assertion evidence source_evidence_literature NP549851.RAicEWBN7xVG4bhl6HHQ8VI5DR4V_bx4SZX96Qpa6nqPM130_provenance.
- NP549851.RAicEWBN7xVG4bhl6HHQ8VI5DR4V_bx4SZX96Qpa6nqPM130_assertion SIO_000772 22694849 NP549851.RAicEWBN7xVG4bhl6HHQ8VI5DR4V_bx4SZX96Qpa6nqPM130_provenance.
- NP549851.RAicEWBN7xVG4bhl6HHQ8VI5DR4V_bx4SZX96Qpa6nqPM130_assertion wasDerivedFrom befree-20140225 NP549851.RAicEWBN7xVG4bhl6HHQ8VI5DR4V_bx4SZX96Qpa6nqPM130_provenance.
- NP549851.RAicEWBN7xVG4bhl6HHQ8VI5DR4V_bx4SZX96Qpa6nqPM130_assertion wasGeneratedBy ECO_0000203 NP549851.RAicEWBN7xVG4bhl6HHQ8VI5DR4V_bx4SZX96Qpa6nqPM130_provenance.